CM082 in Patients With Myopic Choroidal Neovascularization (CNV)

NCT04222842 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

96

Enrollment

INDUSTRY

Sponsor class

Stopped Day is not required for Anticipated dates.

Conditions

Myopic Choroidal Neovascularisation

Interventions

DRUG: CM082

Sponsor

AnewPharma